Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Regulatory News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,907.00
Bid: 1,900.00
Ask: 1,902.00
Change: 2.00 (0.10%)
Spread: 2.00 (0.105%)
Open: 1,916.00
High: 1,927.00
Low: 1,898.00
Prev. Close: 1,905.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

17 Nov 2021 10:35

RNS Number : 6836S
Hikma Pharmaceuticals Plc
17 November 2021
 

TR-1: Standard form for notification of major holdings

 

 LONDON, 17 November 2021 - Hikma Pharmaceuticals PLC (LEI:549300BNS685UXH4JI75) (LSE: HIK) (NasdaqDubai: HIK) announces as follows:

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

 

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Hikma Pharmaceuticals PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

 

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify)iii:

 

3. Details of person subject to the notification obligationiv

Name

BlackRock, Inc.

City and country of registered office (if applicable)

Wilmington, DE, USA

4. Full name of shareholder(s) (if different from 3.)v

Name

 

City and country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reachedvi:

15/11/2021

6. Date on which issuer notified (DD/MM/YYYY):

16/11/2021

7. Total positions of person(s) subject to the notification obligation

 

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

5.00%

0.00%

5.00%

11,607,096

Position of previous notification (if

applicable)

Below 5%

Below 5%

Below 5%

 

       

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB00B0LCW083

 

11,584,532

 

5.00%

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8. A

11,584,532

5.00%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8. B 1

N/A

 

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

CFD

 

 

Cash

22,564

0.00%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8.B.2

22,564

0.00%

 

 

 

          

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

 

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

See Schedule 9, below

 

 

 

 

10. In case of proxy voting, please identify:

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

 

11. Additional informationxvi

 

BlackRock Regulatory Threshold Reporting Team Jana Blumenstein 

020 7743 3650

 

     

 

Place of completion

12 Throgmorton Avenue, London, EC2N 2DL, U.K.

Date of completion

16 November, 2021

 

 

Schedule - Section 9

 

 

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

BlackRock Holdco 2, Inc.

 

 

 

BlackRock Financial Management, Inc.

 

 

 

BlackRock International Holdings, Inc.

 

 

 

BR Jersey International Holdings L.P.

 

 

 

BlackRock (Singapore) Holdco Pte. Ltd.

 

 

 

BlackRock HK Holdco Limited

 

 

 

BlackRock Lux Finco S.a.r.l.

 

 

 

BlackRock Japan Holdings GK

 

 

 

BlackRock Japan Co., Ltd.

 

 

 

Trident Merger, LLC

 

 

 

BlackRock Investment Management, LLC

 

 

 

BlackRock Holdco 2, Inc.

 

 

 

BlackRock Financial Management, Inc.

 

 

 

BlackRock International Holdings, Inc.

 

 

 

BR Jersey International Holdings L.P.

 

 

 

BlackRock Holdco 3, LLC

 

 

 

BlackRock Cayman 1 LP

 

 

 

BlackRock Cayman West Bay Finco Limited

 

 

 

BlackRock Cayman West Bay IV Limited

 

 

 

BlackRock Group Limited

 

 

 

BlackRock Finance Europe Limited

 

 

 

BlackRock Investment Management (UK) Limited

 

 

 

BlackRock Holdco 2, Inc.

 

 

 

BlackRock Financial Management, Inc.

 

 

 

BlackRock International Holdings, Inc.

 

 

 

BR Jersey International Holdings L.P.

 

 

 

BlackRock Australia Holdco Pty. Ltd.

 

 

 

BlackRock Investment Management (Australia) Limited

 

 

 

BlackRock Holdco 2, Inc.

 

 

 

BlackRock Financial Management, Inc.

 

 

 

BlackRock International Holdings, Inc.

 

 

 

BR Jersey International Holdings L.P.

 

 

 

BlackRock Holdco 3, LLC

 

 

 

BlackRock Cayman 1 LP

 

 

 

BlackRock Cayman West Bay Finco Limited

 

 

 

BlackRock Cayman West Bay IV Limited

 

 

 

BlackRock Group Limited

 

 

 

BlackRock International Limited

 

 

 

BlackRock Holdco 2, Inc.

 

 

 

BlackRock Financial Management, Inc.

 

 

 

BlackRock Holdco 4, LLC

 

 

 

BlackRock Holdco 6, LLC

 

 

 

BlackRock Delaware Holdings Inc.

 

 

 

BlackRock Institutional Trust Company, National Association

 

 

 

BlackRock Holdco 2, Inc.

 

 

 

BlackRock Financial Management, Inc.

 

 

 

BlackRock Holdco 4, LLC

 

 

 

BlackRock Holdco 6, LLC

 

 

 

BlackRock Delaware Holdings Inc.

 

 

 

BlackRock Fund Advisors

 

 

 

BlackRock Holdco 2, Inc.

 

 

 

BlackRock Financial Management, Inc.

 

 

 

BlackRock Holdco 2, Inc.

 

 

 

BlackRock Financial Management, Inc.

 

 

 

BlackRock International Holdings, Inc.

 

 

 

BR Jersey International Holdings L.P.

 

 

 

BlackRock (Singapore) Holdco Pte. Ltd.

 

 

 

BlackRock HK Holdco Limited

 

 

 

BlackRock Asset Management North Asia Limited

 

 

 

BlackRock Holdco 2, Inc.

 

 

 

BlackRock Financial Management, Inc.

 

 

 

BlackRock International Holdings, Inc.

 

 

 

BR Jersey International Holdings L.P.

 

 

 

BlackRock Holdco 3, LLC

 

 

 

BlackRock Cayman 1 LP

 

 

 

BlackRock Cayman West Bay Finco Limited

 

 

 

BlackRock Cayman West Bay IV Limited

 

 

 

BlackRock Group Limited

 

 

 

BlackRock Finance Europe Limited

 

 

 

BlackRock (Netherlands) B.V.

 

 

 

BlackRock Asset Management Deutschland AG

 

 

 

BlackRock Holdco 2, Inc.

 

 

 

BlackRock Financial Management, Inc.

 

 

 

BlackRock International Holdings, Inc.

 

 

 

BR Jersey International Holdings L.P.

 

 

 

BlackRock Holdco 3, LLC

 

 

 

BlackRock Canada Holdings LP

 

 

 

BlackRock Canada Holdings ULC

 

 

 

BlackRock Asset Management Canada Limited

 

 

 

BlackRock Holdco 2, Inc.

 

 

 

BlackRock Financial Management, Inc.

 

 

 

BlackRock Capital Holdings, Inc.

 

 

 

BlackRock Advisors, LLC

 

 

 

BlackRock Holdco 2, Inc.

 

 

 

BlackRock Financial Management, Inc.

 

 

 

BlackRock International Holdings, Inc.

 

 

 

BR Jersey International Holdings L.P.

 

 

 

BlackRock Holdco 3, LLC

 

 

 

BlackRock Cayman 1 LP

 

 

 

BlackRock Cayman West Bay Finco Limited

 

 

 

BlackRock Cayman West Bay IV Limited

 

 

 

BlackRock Group Limited

 

 

 

BlackRock Finance Europe Limited

 

 

 

BlackRock Advisors (UK) Limited

 

 

 

BlackRock Holdco 2, Inc.

 

 

 

BlackRock Financial Management, Inc.

 

 

 

BlackRock International Holdings, Inc.

 

 

 

BR Jersey International Holdings L.P.

 

 

 

BlackRock (Singapore) Holdco Pte. Ltd.

 

 

 

BlackRock (Singapore) Limited

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLUBORRAOUAAAA
Date   Source Headline
21st Apr 20217:00 amRNSHikma resumes launch of generic Advair Diskus®
13th Apr 202111:35 amRNSBlock listing Interim Review
13th Apr 20219:19 amRNSTotal Voting Rights
17th Mar 20212:29 pmRNSDirector/PDMR Shareholding
17th Mar 202111:08 amRNSAnnual Financial Report
15th Mar 202111:24 amRNSDirector/PDMR Shareholding
11th Mar 20211:36 pmRNSHikma and GSK agree to cease potential acquisition
2nd Mar 20214:44 pmRNSDirector/PDMR Shareholding
25th Feb 20211:02 pmRNSDirector/PDMR Shareholding
25th Feb 20211:02 pmRNSDirector/PDMR Shareholding
25th Feb 20211:01 pmRNSDirector/PDMR Shareholding
25th Feb 20211:00 pmRNSDirector/PDMR Shareholding
25th Feb 20217:00 amRNSFinal Results
8th Feb 20212:55 pmRNSNotice of Results
26th Jan 20218:01 amRNSPotential Acquisition
15th Jan 20213:59 pmRNSHikma provides update on generic Advair Diskus®
13th Jan 20219:21 amRNSDirector/PDMR Shareholding
13th Jan 20219:14 amRNSDirector/PDMR Shareholding
18th Dec 202010:10 amRNSHolding(s) in Company
17th Dec 20205:30 pmRNSHikma launches generic Advair Diskus®
14th Dec 202012:57 pmRNSHolding(s) in Company
10th Dec 20204:00 pmRNSDirector/PDMR Shareholding
10th Dec 20203:51 pmRNSDirector/PDMR Shareholding
2nd Dec 20203:00 pmRNSTotal Voting Rights
2nd Dec 20201:05 pmRNSHolding(s) in Company
9th Nov 202011:38 amRNSHolding(s) in Company
5th Nov 202011:30 amRNSDirectorate Change
5th Nov 20207:00 amRNSHikma launches Icosapent Ethyl Capsules
5th Nov 20207:00 amRNSTrading Statement
2nd Nov 20201:20 pmRNSTotal Voting Rights
22nd Oct 20201:16 pmRNSNotice to Bondholders
8th Oct 20208:38 amRNSBlocklisting Application
1st Oct 202011:01 amRNSBlock listing Interim Review
22nd Sep 20207:00 amRNSHikma updates on ANDA for generic Advair Diskus®
3rd Sep 20203:15 pmRNSHikma receives favourable court ruling
2nd Sep 20209:30 amRNSTotal Voting Rights
7th Aug 20207:00 amRNSHalf-year Report
3rd Aug 20202:25 pmRNSTotal Voting Rights
16th Jul 202012:06 pmRNSNotice of Results
7th Jul 202012:48 pmRNSPublication of Offering Circular
25th Jun 20204:12 pmRNSHolding(s) in Company
25th Jun 20201:00 pmRNSDirectorate Change
23rd Jun 20205:30 pmRNSHikma Pharmaceuticals
23rd Jun 202011:39 amRNSHolding(s) in Company
23rd Jun 20207:00 amRNSResult of placing in Hikma Pharmaceuticals PLC
23rd Jun 20207:00 amRNSTransaction in Own Shares
22nd Jun 20205:13 pmRNSTransaction in Own Shares
22nd Jun 20205:09 pmRNSProposed Placing in Hikma Pharmaceuticals PLC
22nd Jun 202011:24 amRNSDirector/PDMR Shareholding
22nd Jun 202011:22 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.